Ardena has completed the process of divesting its active pharmaceutical ingredient (API) site in Södertälje, Sweden, to Nanologica AB.
Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical ...
Ardena completes divestment of its Södertälje drug substance site in Sweden to NanologicaGhent, Belgium, 29th January 2026 – Ardena, a specialist CDMO and bioanalytical CRO enabling precision ...
HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...
The pipe fitting industry is experiencing robust growth, driven by urbanization, industrial modernization, and investment in ...
PINE COUNTY, Minn. – The United States Pipeline and Hazardous Materials Safety Administration (PHMSA) is overseeing the ...
HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...
WHAT’S HAPPENING TODAY: Good afternoon and happy Thursday, readers! We hope you’re staying warm despite the frigid ...
Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
The Fine and Specialty Chemicals Market is entering a transformative phase of high-value innovation and application-specific ...
1d
Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...
Cloud adoption has moved beyond migration and cost optimization to shape how enterprises build, run, and scale their core systems. In a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results